… Overuse of short-acting β 2 -agonists in asthma is associated with increased risk of
exacerbation and mortality: a nationwide cohort study of the global SABINA programme …

… Activated B 2 Rs are endocytosed along its agonist (modeled with B 2 R-GFP and CF-εACA-BK,
respectively), while the β-arrestin is translocated from its uniform cytosolic distribution to …

… Assist use of inhaled short-acting beta 2 agonists (SABAs) is reportedly effective for preventing
shortness of breath on exertion in chronic obstructive pulmonary disease (COPD) patients…

… can be mitigated by treatment with β-AR antagonists, or enhanced by β-AR agonists. This
strongly supports the possibility that reducing stress-induced activation of β2-ARs could help to …

… by the stimulation of β 3 -AR. Oral administration of the β 3 -AR agonist mirabegron only
elicited … This led to off-target binding to β 1 -AR and β 2 -AR, thereby increasing cardiovascular …

… In addition, a major role of β2 receptors is dilation of coronary arteries in response to stress.
β2 adrenergic agonists are used as mainstay treatments for respiratory diseases such as …

… 2) [23], [24]. Several studies have also investigated β-arrestin recruitment by CB 2 , although
… The recruitment of β-arrestin2 to CB 2 has been demonstrated using the PathHunter® and …

… β 2 AR(β 1 LBP) converted the behavior of β 2 AR to that of β 1 AR. Adding the converse
residues from β 2 AR into β 1 AR, to make the mutant β 1 AR(β 2 … site in β 1 AR to that of β 2 AR (…

… To explore mechanisms by which tirzepatide resulted in greater reductions of hyperglycemia
than a selective GLP-1 receptor agonist, we conducted post hoc exploratory analyses of …

… and wheezing requiring systemic corticosteroids and inhaled β2 agonist. … , 2 patients during
p2, and 5 patients were treated with systemic corticosteroids and inhaled β2 agonist during …